Rahul Dalal, MD, MPH

Brigham and Women's Hospital
Boston, MA

Presentation(s):

• 42 - One-Year Comparative Effectiveness of Ustekinumab vs Tofacitinib for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure

  Tuesday, October 25, 2022
  3:05 PM – 3:15 PM ET